About Biovian
Biovian is a company based in Turku (Finland) founded in 2003 by Antti Nieminen and Jani Yomaa was acquired by Keensight Capital in May 2018.. Biovian offers products and services including Microbial Proteins, Viral Vectors, Plasmid DNA, Cell Therapies, and Aseptic Fill & Finish. Biovian operates in a competitive market with competitors including Syngene, Abzena, Piramal Group, Patheon and Maravai Life Sciences, among others.
- Headquarter Turku, Finland
- Founders Antti Nieminen, Jani Yomaa
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Edmond de Rothschild
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Keensight Capital
(May 23, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biovian
Biovian offers a comprehensive portfolio of products and services, including Microbial Proteins, Viral Vectors, Plasmid DNA, Cell Therapies, and Aseptic Fill & Finish. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for developing and producing microbial proteins for biologics.
Manufacturing of vectors like AAV and adenovirus for gene therapies.
Production of plasmid DNA for research and therapeutic applications.
Development and manufacturing of cell-based therapies for medical use.
Aseptic processing and packaging for biologic drug products.
Funding Insights of Biovian
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biovian
Biovian has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Edmond de Rothschild and Keensight Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Keensight Capital is recognized as a European Growth Buyout investor.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biovian
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biovian
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biovian Comparisons
Competitors of Biovian
Biovian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Piramal Group, Patheon and Maravai Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biovian
Frequently Asked Questions about Biovian
When was Biovian founded?
Biovian was founded in 2003.
Where is Biovian located?
Biovian is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.
Who is the current CEO of Biovian?
Antti Nieminen is the current CEO of Biovian. They have also founded this company.
What does Biovian do?
Founded in 2003 in Turku, Finland, diversified CDMO services are offered by Biovian within the biopharmaceutical sector. Operations center on viral vector production, microbial synthesis of recombinant proteins, and plasmid DNA manufacturing. GMP-compliant processes encompass microbial fermentation, mammalian cell culture, protein purification, formulation, aseptic filling and finishing, analytical quality control, stability testing, master and working cell bank production with storage, drug product labeling, packaging, storage, and qualified person release.
Who are the top competitors of Biovian?
Biovian's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
What products or services does Biovian offer?
Biovian offers Microbial Proteins, Viral Vectors, Plasmid DNA, Cell Therapies, and Aseptic Fill & Finish.
Who are Biovian's investors?
Biovian has 2 investors. Key investors include Edmond de Rothschild, and Keensight Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.